IJPR  artciles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 1.55 (2012 - 2016). 

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

ISSN
0975-2366
5 - Years Impact Factor

Year 2012 - 2016

Impact Factor: 1.55

Total Publications: 317

Total Citation: 491

Year 2011 - 2015

Impact Factor: 1.46

Total Publications: 326

Total Citation: 477

Year 2010 - 2014

Impact Factor: 1.3

Total Publications: 313

Total Citation: 407

Year 2009 - 2013

Impact Factor: 0.973

Total Publications: 293

Total Citation: 285

Current Issue
22nd NATIONAL CONVENTION

22nd National Convention of Society of Pharmacognosy & International Conference. For more details visit


For More Detail Visit ncsp.ganpatuniversity.ac.in
Article In Press
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPRT ISSUE

January - March 6 [1] 2014

Click to download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
PIPPHARMACON & IJPR 2018

PIPPHARMACON & IJPR 2018

Click to download
 

Article Detail

Label
Label
Stability Indicating RP-HPLC Method for the Estimation of Plerixafor and its

Author: PINGALI SRIDEVI, VINUTHA.K, MAHESH.K, AKSHITHA.M, BHAGAVAN RAJU.M , KEERTHI CHAND
Abstract: Developed and validated a stability indicating reversed phase high performance liquid chromatographic method (RPHPLC) for the estimation of plerixafor and its impurities in bulk and parenteral dosage form. The method was carried out using Zorbax eclipse C18 column (250 x 4.6mm, 5?m) with mobile phase-A and mobile phase-B, where mobile phase-A consists of 1-Hexane sulphonic acid sodium salt buffer and mobile phase-B consists of Acetonitrile and water in the ratio of 80:20 (v/v) under gradient mode with an injection volume of 10µL at flow rate of 1ml/min and the detection was carried out at 210 nm. The retention time of the plerixafor for assay and RS method were found to be 14.17min and 21.68min. The assay method showed linear response in the concentration range of 200-600µg/ml with a correlation coefficient of 0.999 and for RS method in the concentration range of LOQ to 200% with a correlation coefficient of 0.998. The method precision for the determination of assay was below 2% RSD and the percentage recovery of plerixafor was found to be 99.47. Plerixafor was subjected to stress conditions like acidic, alkaline and oxidation degradations. The degradation products were well separated from each other and with the main peak. The proposed method was validated as per ICH guidelines. The method was found to be linear, specific, precise and accurate. Therefore, the proposed method can be used for the routine analysis of drug in the process control of bulk and pharmaceutical formulation.
Keyword: Plerixafor, Potential impurities, RP-HPLC, Validation, Stability indicating
Download: Request For Article
 












USER LOGIN


Username
Password
Login | Register
AICTE INTERNATIONAL CONFERENCE

AICTE Sponsored International Conference on Challenges, Opportunities and Newer Directions of Pharmacovigilance and Clinical Research in India

Download Brochure


For More Detail Visit www.pippharmacon.org
News & Events
0.07
2017CiteScore
 
11th percentile
Powered by  Scopus
Impact Factor for five years is 1.55 (2012 - 2016)
Year 2011 - 2015 Impact Factor - 1.46 Total Publications - 326 Total Citations - 477